基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 原料药 呼吸系统用药 镇咳药 厄多司坦 厄多司坦;RV 144
  • 厄多司坦;RV 144-abs817111
  • 厄多司坦;RV 144-abs817111

1/2

厄多司坦;RV 144-abs817111

现货
Erdosteine
¥795 1g 起订
¥515 500mg 起订
上海 更新日期:2026-11-16

爱必信(上海)生物科技有限公司

VIP7年

科技型中小企业

高新技术企业

联系人:爱必信
手机:13761418683 拨打
邮箱:fengmj@univ-bio.com

产品详情:

中文名称:
厄多司坦;RV 144
英文名称:
Erdosteine
CAS号:
84611-23-4
品牌:
Absin
纯度规格:
<p>99%</p>
产品类别:
其它
货号:
abs817111
一、产品概述

厄多司坦;RV 144 是来自Absin品牌的高品质产品,适用于科研实验领域。

更多产品描述请查看优宁维旗下爱必信官网(https://www.absin.cn/erdosteine/abs817111.html?mk_channel=chemicalbook)

二、产品信息
货号abs817111
SKU货号abs817111-500mg
品牌Absin
中文名称厄多司坦;RV 144
英文名称Erdosteine
CAS号84611-23-4
纯度

99%

分子量249.3
可溶性Ethanol : 10 mg/mL (40.11 mM)
DMSO : 50 mg/mL (200.55 mM)
外观白色或类白色结晶性粉末
抗原名称Adenosine deaminase,NF-κB
商品描述

Erdosteine is a mucolytic. Erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis. Erdosteine contains 2 blocked sulfhydryl groups which are released following first-pass metabolism. The 3 active metabolites exhibit mucolytic and free radical scavenging activity. Erdosteine modulates mucus production and viscosity and increases mucociliary transport, thereby improving expectoration. It also exhibits inhibitory activity against the effects of free radicals produced by cigarette smoke. Clinical studies in patients with chronic obstructive lung disease have demonstrated the efficacy and tolerability of erdosteine. Erdosteine 300mg twice daily reduced cough (both frequency and severity) and sputum viscosity more quickly and more effectively than placebo and reduced the adhesivity of sputum more effectively than ambroxol 30mg twice daily. Co-administration of erdosteine and amoxicillin in patients with acute infective exacerbation of chronic bronchitis resulted in higher concentrations of the antibiotic in the sputum, leading to earlier and more pronounced amelioration of clinical symptoms compared with placebo. Erdosteine is associated with a low incidence of adverse events, most of which are gastrointestinal and generally mild.

In vitro(体外研究)
Erdosteine is an oral mucolytic agent used as an expectorant in various chronic respiratory diseases. Erdosteine exerts anti-inflammatory effects by inhibiting NF-κB activation in LPS-stimulated mouse macrophages. However, Erdosteine does not inhibit LPS induced phosphorylation of the Akt and MAPK pathways. To evaluate the toxic effects of Erdosteine on macrophages, cell viability is analyzed. Treatment with 1, 10, or 100 μg/mL Erdosteine does not produce detectable cytotoxicity. Treatment with LPS (1 μg/mL) induced IκBα degradation in RAW 264.7 cells, and maximal degradation is observed after 10 min. RAW 264.7 cells are pretreated with the indicated concentrations of Erdosteine for 6 h and then stimulated with LPS (1 μg/mL) for 10 min. Pretreatment with Erdosteine does not have any effect on the baseline amount of IκBα. Treatment with DMSO alone at a volume equal to that used for Erdosteine delivery does not have any effect on the baseline amount of IκBα. The amount of IκBα is decreased by treatment with LPS for 10 min, and pretreatment with Erdosteine at the indicated concentration and time effectively inhibits IκBα degradation.
In vivo(体内研究)
Twenty-six male mice are divided into four groups as follows: group 1, control; group 2, Erdosteine-treated; group 3, Methotrexate (MTX)-treated; and group 4, Methotrexate+Erdosteine treated. On the first day of experiment, a single dose of Methotrexate is intraperitoneally administered to groups 3 and 4, although a daily single dose of Erdosteine is orally administered to group 2 and 4 for 7 days. At the end of the experiment, the testes of the animals are removed and weighed. The levels of total antioxidant capacity and total oxidative stress, and myeloperoxidase activity in the Methotrexate group are higher than the control group (p<0.05). Lipid peroxidation levels are not changed in Methotrexate group compared with control group. In conclusion, Erdosteine can effectively protect the testes in Methotrexate-induced toxicity. Erdosteine administration with Methotrexate improves testicular injures, as indicated by appearance of spermatogenesis in seminiferous tubules.
三、背景
别名厄多司坦;RV 144
CAS号84611-23-4
四、制备和贮存
保存方式Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
五、产品特点
  • 品质保证:经过严格的质量控制,确保产品的高品质和稳定性。
  • 高纯度:纯度达到<p>99%</p>。
六、注意事项
  • 本产品仅供科学研究使用,不可用于临床诊断或治疗。
  • 请在通风良好的环境下操作,佩戴适当的个人防护装备。
  • 如不慎接触皮肤或眼睛,请立即用大量清水冲洗并就医。
,厄多司坦,RV 144

公司简介

爱必信是优宁维生物旗下自主品牌,是一家从事生物学试剂及耗材的高新技术企业。公司秉承“为生命科学创造便利!为客户创造价值!为员工创造幸福人生!”的发展理念,拥有专业的产品研发质检团队、市场营销团队及先进仓储物流等管理团队。荣获2021年度上海市“专精特新”企业称号。 主要经营产品有:生化试剂(常用生化试剂、生物学实验常用试剂、荧光染料、激动剂/抑制剂,植物提取物)、细胞生物学(细胞培养产品、血清、基质胶、添加剂、检测试剂盒)、免疫学产品、分子生物学产品、实验室仪器/耗材、产品定制和检测服务。 Absin还提供一些独有的特色产品:霍乱毒素B亚单位(CTB)、 鸡胚提取物(CEE)、 牛脑垂体提取物、 呼吸爆发试剂盒、 多色免疫组化试剂盒、 mRNA原料等在业界深受客户喜欢。 Absin秉承踏实,务实,求精和不断创新的精神为中国科学家提供优质产品,努力打造属于中国自己的生物试剂品牌,为广大科学家提供更全面更丰富更优质的产品。 爱科研,必信它(Absin)! Absin-生命科学百宝箱∑! 欢迎访问我们网站:www.absin.cn, 更多产品、更多便利,就在你身边!

成立日期 (16年)
注册资本 2500万
员工人数 100-500人
年营业额 ¥ 1000万-5000万
经营模式 工厂,试剂,定制,服务
主营行业 生化试剂,抗体,分子生物学,生物活性小分子

厄多司坦;RV 144相关厂家报价 更多

  • 厄多司坦
  • 厄多司坦
  • 湖北威德利化学科技有限公司 VIP
  • 2026-11-13
  • ¥3500
内容声明
拨打电话 立即询价